Saturday, May 30, 2026

THE ORGAN — VII · The Spain Divergence

The Organ · Post VII · The Spain Divergence
Trium Publishing House
Forensic System Architecture
thegipster.blogspot.com
Est. 2026 · Pennsylvania
The Organ
Post VII of VIII
ORG-POST-VII  ·  COMPARATIVE-ARCHITECTURE  ·  STRUCTURAL CONTRAST

The Spain
Divergence

52.6 Donors Per Million · 37 Consecutive Years Leading the World · The Architecture That Produces It

Spain has led the world in deceased organ donation rates for 37 consecutive years. In 2024 it set a new global record: 52.6 donors per million population. The US managed 48.1 — apparently close, but with a discard rate three to four times Spain's, making effective utilization substantially lower. Spain did not achieve this through altruism or luck. It built a different architecture. The difference is structural, not cultural.

Spain · 2024 Record
52.6
Donors per million · All-time global record
United States
~48.1
Donors per million · High discard rate offsets raw number
France
27.6
Donors per million · Presumed consent · Significant gap
EU Average
~22.9
Donors per million · 2023 · Well below Spain
Germany
11.6
Donors per million · Europe's largest economy · Lowest rate
01 What Spain Is Not

The standard explanation for Spain's donation rates begins with presumed consent — Spain's opt-out system, in place since 1979, which designates every citizen a potential donor unless they register an objection. This explanation is incomplete to the point of being misleading.

Spain's opt-out law predates Spain's exceptional donation rates by a decade. Donation rates in Spain were not remarkable in the 1980s. They began their sustained climb after 1989 — not because the law changed, but because the infrastructure changed. The Organización Nacional de Trasplantes, created in 1989, built a new coordination architecture that transformed Spain's performance. The law was the same. The system was different. The results diverged.

This matters because the policy debate in the US and UK frequently focuses on presumed consent legislation as the mechanism for improving donation rates. The Spanish evidence does not support that focus. Countries that have adopted presumed consent without the accompanying organizational infrastructure have seen modest or negligible improvements. The law is a necessary condition for the soft presumed consent environment Spain operates in. It is not sufficient. The architecture is what's sufficient.

Common Explanation
Spain Succeeds Because of Presumed Consent
Spain's opt-out law, in place since 1979, means citizens are presumed donors unless they register objection. This legal default, the argument runs, is what drives Spain's world-leading donation rates — more potential donors become actual donors because inertia favors donation rather than non-donation.

Policy implication: Adopt presumed consent and donation rates will improve.
What the Evidence Shows
Spain Succeeds Because of Organizational Architecture
Spain's opt-out law has been in place since 1979. Spain's exceptional donation rates began after 1989 — when the ONT was created and hospital transplant coordinators were professionalized and embedded in ICUs. Countries that adopted presumed consent without the organizational model saw marginal gains. The law created the enabling environment. The architecture produced the results.

Policy implication: Build the coordinator infrastructure, invest in hospital relationships, professionalize family communication. The law is secondary.
02 The ONT Architecture

The Organización Nacional de Trasplantes — the ONT — is a national technical agency under Spain's Ministry of Health, created in 1989. It operates on three tiers: the national ONT provides strategy, coordination, logistics support, and quality oversight; regional coordinators manage inter-hospital coordination within Spain's autonomous communities; and hospital transplant coordinators — the model's most important innovation — are embedded within individual hospitals as full members of the clinical staff.

The hospital coordinator is not an external representative of a procurement organization arriving in the ICU after a death. They are a physician or nurse who works in the hospital every day, who has relationships with the ICU team, who is present in the daily clinical environment, and who approaches potential donor families as a member of the care team that has been involved in that patient's treatment — not as an outsider arriving for a transactional purpose.

This structural position changes everything about the family approach. The conversation about donation happens in the context of an established relationship with the care team. The coordinator has been trained specifically in empathetic communication and grief support — not as an add-on to a clinical role, but as the primary skill the role requires. Spain's family refusal rate runs at approximately 15 to 20 percent. The US national average is substantially higher.

Spain did not ask families to donate more generously. It built a system in which the person asking is the person who cared for their family member — present throughout, known, trusted. The architecture of the relationship produces the rate. The rate is not evidence of Spanish generosity. It is evidence of Spanish organizational design.

03 The Performance Numbers
Deceased Donor Rates · Selected Countries · Donors Per Million Population · 2023–2024 ORG-POST-VII · PC-01
Spain
Global Record · 37 consecutive years leading
52.6 pmp
USA
High discard rate reduces effective yield
~48.1 pmp
Croatia
Adopted elements of Spanish Model
~37 pmp
France
Presumed consent · Organizational gap
27.6 pmp
UK
~22.4 pmp
EU Average
~22.9 pmp
Germany
11.6 pmp
Raw donation rates do not capture effective transplant yield. US high discard rate (~27%) means effective utilization substantially lower than raw pmp suggests. Spain discard rate: significantly lower. Organs recovered in Spain are more likely to be transplanted.
04 The Coordinator Model · Spain vs. US

The single most structurally significant difference between the Spanish and American models is where the procurement coordinator sits — institutionally, physically, and relationally. In Spain, the coordinator is inside the hospital. In the US, the OPO coordinator is outside it. This positional difference is the architectural key to the performance divergence.

Spanish Model · Hospital Coordinator
Embedded · Internal · Trusted
Professional Profile
Typically an intensive care physician or nurse with 5+ years clinical experience. Appointed by hospital management. Part of the hospital staff roster. Has clinical authority and institutional standing within the ICU environment.
Daily Role
Screens ICU admissions every day using clinical triggers — not waiting for death to occur before engagement. Participates in end-of-life care discussions as a routine clinical participant. Builds relationships with ICU teams over years of shared work.
Family Approach
Approaches families as a member of the team that has been caring for the patient throughout their ICU admission. Receives specialized training in grief communication. Long contact time — not a single transactional conversation.
Conflict of Interest
Explicitly not part of the transplant team. Spanish model requires coordinators to be separated from the transplant surgical team to eliminate pressure on donor management for recipient outcomes.
US Model · OPO Coordinator
External · Transactional · Arriving
Professional Profile
Employed by the OPO — an external nonprofit organization with procurement rights in the territory. Variable clinical background. Arrives at the hospital when potential donation is identified, not as an ongoing clinical presence.
Daily Role
Responds to referrals from hospital staff when a potential donor is identified. Passive waiting for referral rather than proactive daily screening. Relationship with hospital ICU staff dependent on individual OPO investment and hospital culture.
Family Approach
Approaches families typically as a stranger — representing an organization the family has not previously encountered, arriving at the worst moment, without the established relationship that Spanish coordinators bring to the same conversation.
Financial Incentive
OPO is financially incentivized to obtain consent — it is reimbursed per organ recovered. This incentive structure is the opposite of the Spanish model's explicit separation from recovery incentives.
05 The Full Architectural Comparison

Mapped against the FSA framework, the Spanish and American systems are not different versions of the same architecture. They are different architectures that happen to address the same problem. The source layer — deceased donors and their families — is the same. Every other layer diverges.

FSA Architecture · Spain vs. United States · Layer-by-Layer Comparison ORG-POST-VII · AC-01
Layer
Spain · ONT Model
United States · UNOS / OPO Model
Source
Deceased donors. Soft presumed consent (1979) with mandatory family consultation. Family refusal rate ~15–20%. Proactive identification via in-house coordinators screening ICUs daily.
Lower Refusal Rate
Deceased donors. Opt-in (explicit registration) plus next-of-kin consent. Family refusal rates higher nationally. Reactive identification — OPO notified by hospital when potential donor identified.
Higher Refusal Rate
Conduit
In-house hospital coordinators — ~185 authorized hospitals, minimum 2 coordinators each, 24/7 coverage. Embedded in ICU. Part of care team. Proactive daily engagement. No financial incentive tied to procurement volume.
Structural Advantage
57 regional OPO monopolies. External to hospital. Reactive. Performance varies 2:1 across territories. Financially incentivized per organ recovered. No competitive accountability until 2020 metrics reform.
Structural Disadvantage
Conversion
ONT national allocation with regional execution. Discard rates significantly lower than US. Risk aversion mitigated by national coordination and different center incentive structure.
Lower Discard Rate
UNOS algorithm. 20–29% kidney discard rate. Center risk aversion driven by outcomes reporting metrics. High-KDPI organs face long decline chains. Post-2023 reforms addressing but not yet resolved.
High Discard Rate
Governance
ONT as national public agency under Ministry of Health. Created 1989. National strategy, regional coordination, local execution. Public accountability. Manages WHO Global Observatory on Donation and Transplantation.
Public Accountability
UNOS as private nonprofit contractor, 1986–2023. Board populated by governed professionals. Funded by member fees from regulated entities. Senate investigation documented governance failures. 2023 reform ongoing.
Structural Conflicts
Insulation
Limited structural insulation. ONT is publicly funded, publicly accountable, and subject to Ministry of Health oversight. Performance data is public. Failures are governmental failures — attributable and politically costly.
Accountability Maintained
"Science-based allocation." "Nonprofit mission." "Life-saving." Governance structure conflated regulated and regulator. Disruption risk argument insulated against competitive rebid. Senate investigation required to produce reform.
Heavy Insulation
06 What the US Studied and Didn't Do

The Spanish Model is not unknown to American transplant medicine. The IOM, the GAO, and academic researchers have examined it for decades. Spanish coordinators and ONT leadership have presented at American conferences. The TPM training program, run by the DTI Foundation linked to the University of Barcelona, has trained coordinators from over 100 countries. American OPO staff have attended those programs.

What the US has not done is adopt the core structural innovation: embedding coordinators inside hospitals as full members of the clinical staff, with hospital funding, clinical standing, and no financial incentive tied to procurement volume. The elements the US has selectively adopted — better family communication training, proactive referral protocols, some performance metrics — are the surface features of the Spanish Model without its structural foundation.

The reason is not ignorance. It is architecture. Embedding coordinators inside hospitals would require hospitals to fund them, which hospitals resist. It would require OPOs to surrender the family approach role, which OPOs resist. It would require the territorial monopoly structure to be disrupted, because in-hospital coordinators would not align neatly with regional OPO boundaries. Every element of the Spanish Model's structural innovation conflicts with the existing US institutional arrangement. The US has studied Spain for decades and learned without implementing because implementation would require dismantling the architecture that this series has documented.

52.6
Spain · 2024
Donors per million population — highest figure ever recorded anywhere in the world
37
Years Leading
Consecutive years Spain has led the world in deceased donor rates — the ONT was created in 1989
~15%
Family Refusal
Spain's family refusal rate for donation — significantly below the US national rate, achieved through coordinator architecture, not law
27%
US Discard Rate
US kidney discard rate — Spain's is significantly lower, making effective transplant yield per recovered organ substantially higher
FSA Note · Structural Contrast

The Spain divergence is the series' most direct evidence that the American organ transplant architecture is not the only possible architecture — it is a choice. The outcomes Spain achieves are achievable. The organizational model that produces them is documented, exportable (the TPM program has trained coordinators in 100+ countries), and well understood by American transplant medicine. The gap between knowing what Spain does and doing it is not a knowledge gap. It is an architecture gap — the existing US institutional arrangement conflicts at every structural layer with the model that produces better outcomes. The discard rate, the OPO performance variation, the governance conflicts, the contractor monopoly — each of these problems has a Spanish analog that was solved by building the architecture differently. The US has studied the solution for decades. The study has not produced the implementation, because implementation would require dismantling what already exists. That is the most important finding of the series.


Final Post · Post VIII · The Modernization — 2023 Securing the US OPTN Act. Multi-vendor rebid. What the reform has produced and what it has not. Whether competition replaced capture or redistributed it.

THE ORGAN — VI · The Contract

The Organ · Post VI · The Contract
Trium Publishing House
Forensic System Architecture
thegipster.blogspot.com
Est. 2026 · Pennsylvania
The Organ
Post VI of VIII
ORG-POST-VI  ·  PROCUREMENT-RECORD  ·  CONTRACT ARCHITECTURE

The Contract

NOTA 1984 · The Rebid That Never Happened · How Incumbency Becomes Monopoly

The National Organ Transplant Act of 1984 made two reasonable decisions. It created a private nonprofit contractor model to avoid government bureaucracy. It prohibited organ sales to prevent commodification. Neither decision was wrong for 1984. Together, they created the structural conditions for a single organization to hold life-and-death allocation authority for 37 years without a competitive challenge.

Legislation
NOTA · Pub. L. 98-507 · 1984
Contractor
UNOS · Richmond, VA
Award Type
Single vendor · Each renewal
Period
1986 — 2023 / 2024
Competitive Rebid
None in 37 years
01 The 1984 Decisions

Nineteen eighty-four was a particular moment in American transplant medicine. Cyclosporine, introduced in 1983, had dramatically improved organ rejection rates and made transplantation viable for a much wider patient population. The number of transplant centers was growing. The number of patients who could benefit from transplant was growing faster. The ad hoc regional coordination systems that had developed — including the Southeast Organ Procurement Foundation and the North American Transplant Coordinators Organization — were insufficient for national scale. Congress acted.

The National Organ Transplant Act made two structural choices that would shape the system for the next four decades. First, it created the Organ Procurement and Transplantation Network as a private nonprofit contractor rather than a new government agency. Second, it prohibited compensation for organ donation, establishing the altruistic framework that continues to govern American organ procurement. Both choices were defensible responses to the conditions of 1984. Neither choice was made with full anticipation of its long-term consequences.

NOTA 1984 · Key Provisions · Intent vs. Consequence ORG-POST-VI · NOTA-01
Provision
Legislative Intent · 1984
Structural Consequence · Realized
Private nonprofit OPTN contractor
Avoid creating a new government bureaucracy. Leverage the clinical expertise and existing relationships of the transplant professional community. Enable flexible, expert-driven governance of a technically complex medical system.
Created conditions for a single incumbent organization to accumulate decades of institutional knowledge, proprietary data infrastructure, and political position — making meaningful competition at each renewal cycle practically impossible without disrupting patient care.
Prohibition on organ sales (§301)
Prevent commodification of organ donation. Preserve the altruistic basis of the gift relationship. Align with WHO and international ethical norms favoring voluntary unpaid donation.
Maintained the ethical framework for donation that has broad public support. Also created structural scarcity — with no price signal to increase supply, allocation rather than market mechanisms must govern distribution. The quality of allocation architecture becomes the critical variable.
HHS oversight of OPTN contract
Federal accountability for the national system. HRSA to award and oversee the contract; CMS to certify and reimburse OPOs. Distributed oversight across the existing agency structure.
Distributed oversight with no unified accountability mandate. HRSA oversaw the contractor; CMS oversaw the OPOs; neither was clearly responsible for the system's aggregate performance. The gap between agencies became the gap in accountability that this series has documented.
OPTN membership mandatory for transplant centers
Ensure all centers participate in the national system, enabling consistent data collection, allocation policy application, and quality standards across all transplant programs.
Mandatory membership created the revenue architecture examined in Post V: every transplant center must pay fees to the organization governing them. The regulator's financial dependence on the regulated was structurally embedded from the beginning.
02 The Rebid That Never Happened

HRSA had the authority to competitively rebid the OPTN contract at each renewal cycle. The law did not prohibit competition — it specified a private nonprofit contractor, not UNOS specifically. In principle, any qualified nonprofit organization could have submitted a competing proposal at any renewal. In practice, no competitor ever successfully challenged UNOS's hold on the contract across 37 years and multiple renewal cycles.

Understanding why requires understanding what the OPTN contract actually entailed at each renewal. By the time of the first renewal, UNOS had built the UNet matching system — proprietary software that managed the national waitlist and ran the allocation algorithm. It had established working relationships with all 57 OPOs and hundreds of transplant centers. It had accumulated years of historical data on donor and recipient outcomes. It employed the staff with institutional knowledge of the system's operations. A competitor proposing to take over the OPTN contract would have been proposing to rebuild all of this from scratch — while patients remained on the waitlist and organs continued to require matching in real time.

HRSA did not protect UNOS's monopoly. It failed to challenge it. The difference matters. Active protection implies conspiracy. Passive failure implies something more common and more durable: the risk calculus of disruption outweighing the cost of incumbency, every renewal cycle, for 37 years.

OPTN Contract · Renewal Record · 1986–2023 ORG-POST-VI · RT-01
1984
NOTA enacted
Founding Law
National Organ Transplant Act
Congress creates OPTN as private nonprofit contractor model. Prohibits organ sales. Mandates HHS oversight via HRSA. Does not name UNOS — creates the position, not the occupant.
1986
First award
Initial Award
UNOS awarded first OPTN contract
HRSA awards to UNOS, evolving from SEOPF regional network. UNOS has existing infrastructure, relationships, and technical capability. Reasonable first award. The 37-year clock starts.
1990s
Early renewals
No Rebid
Contract renewed · No competitive challenge
UNOS builds UNet system. Accumulates proprietary data. Establishes relationships with all OPOs and transplant centers. Each renewal increases switching cost. No credible competitor emerges. HRSA accepts — switching risks real, performance concerns not yet critical.
2000s
Multiple renewals
No Rebid
GAO reports document performance gaps · Contract continues
Multiple GAO and OIG reports identify oversight weaknesses, data transparency issues, and governance concerns. HRSA responds with process requirements. UNOS agrees with recommendations. Contract renewed. Performance improvement within existing structure is the default response — not structural change.
2010s
Pressure builds
No Rebid
Media exposĆ©s, whistleblowers, reform advocacy · Contract continues
LA Times, NYT, and investigative outlets document operational failures. Whistleblowers raise safety concerns. Patient advocacy organizations push for reform. HRSA conducts reviews. UNOS implements improvements. Contract renewed. The disruption argument holds: changing the system mid-operation risks patient harm.
2019–22
Reckoning
No Rebid Yet
Senate Finance Committee investigation · Documented failures
Wyden/Grassley investigation documents complaint handling failures, IT security gaps, governance conflicts, executive compensation, and operational safety incidents. The congressional record now contains specific, documented failures with named consequences. The disruption argument becomes harder to sustain than the accountability argument.
2023
Legislative action
Reform
Securing the US OPTN Act · Multi-vendor rebid
Congress passes legislation breaking the single contract into competitive components. HRSA announces OPTN Modernization Initiative. Multiple vendors awarded pieces. UNOS retains some components; others go to new contractors. 37-year monopoly formally ends. The legislative mechanism was required because the administrative mechanism had not produced reform in four decades.
03 The Lock-In Mechanisms

The durability of UNOS's contract position is explained by four interlocking mechanisms that accumulated over time, each reinforcing the others. None was designed to prevent competition. All had that effect.

Incumbency Lock-In Mechanisms · UNOS Contract Position ORG-POST-VI · LI-01
Data Lock-In
Proprietary Historical Record
UNOS held decades of waitlist data, outcome records, and allocation history — all in proprietary UNet infrastructure with limited government access. A competitor would begin without this data. Outcomes research, algorithm refinement, and policy analysis all depend on historical data the incumbent controlled. HRSA did not have full access to the system it was funding.
Relationship Lock-In
Institutional Network Dependency
UNOS had operating relationships with all 57 OPOs, hundreds of transplant centers, and thousands of transplant professionals over decades. These relationships governed the daily coordination of organ procurement and allocation. A new contractor would inherit the formal mandate but not the institutional trust and working relationships built over 37 years.
Technical Lock-In
UNet System Complexity
The UNet matching system — proprietary code running the national organ allocation algorithm — represented enormous accumulated technical investment. Replicating it would require years and significant resources. During any transition, organ allocation would continue to operate. The risk of transition errors in a life-critical system was a genuine argument against changing contractors, used effectively against competition.
Political Lock-In
Disruption Risk Argument
Any proposal to change the OPTN contractor could be opposed on patient safety grounds — disrupting a life-critical system risks patient harm. UNOS and its allies in the transplant professional community deployed this argument at each reform moment. It was not dishonest. Transition does carry risk. But it was also structurally convenient for the incumbent, and it was used to resist accountability as effectively as it was used to protect patients.
04 The Switching Cost Analysis

The formal mechanism for maintaining competition in government contracting is the competitive rebid — requiring the incumbent to compete against other qualified bidders at each renewal. For most federal contracts, this works reasonably well. For the OPTN contract, it faced a specific problem: the switching costs were genuine, and they were denominated in patient lives.

OPTN Contract · Switching Cost Analysis · Why Rebidding Was Resisted ORG-POST-VI · SC-01
Cost Category
Description
Severity
Data migration
Moving decades of waitlist records, outcome data, and allocation history from proprietary UNOS infrastructure to a new contractor's systems. Risk of data loss, integrity failures, and gaps in the allocation record.
High
Algorithm continuity
A new contractor would need to replicate or replace the UNet matching algorithm. Any changes to allocation logic affect which patients receive organs. Algorithm transition during active waitlist operation risks systematic misallocation.
Critical
OPO relationship disruption
57 OPOs have established protocols, communication channels, and working relationships with UNOS staff. A new contractor would need to rebuild these operational relationships while organs were being recovered and allocated in real time.
High
Institutional knowledge loss
UNOS staff held decades of institutional knowledge about edge cases, policy interpretations, and operational practices not fully documented in any contract or manual. This knowledge cannot be transferred — it must be rebuilt.
High
Transition window risk
The period between contract handoff and full operational capability of a new contractor is a period of elevated error risk in a system where errors can be fatal. No equivalent federal contract manages a similarly life-critical real-time operational system.
Critical
Political opposition
Any rebid proposal would trigger organized opposition from UNOS, the transplant professional community, and patient advocacy groups aligned with system continuity. The incumbent could always argue that competition risked patient harm. This argument is not false — but it also protects the incumbent from accountability.
Structural
05 The 2023 Solution

The Securing the US OPTN Act of 2023 solved the switching cost problem by not trying to switch the whole system at once. Instead of a single competitive rebid — which would face all of the transition risks described above simultaneously — the legislation broke the OPTN contract into functional components: IT and matching systems, operations, safety oversight, governance support, and research. Each component could be competitively awarded separately. A new IT contractor could take over the UNet system over time while UNOS continued operating the matching algorithm. A new safety organization could provide oversight without disrupting procurement logistics.

This was the right structural solution. It addressed the lock-in mechanisms directly — the data lock-in through IT separation, the algorithm continuity risk through staged transition, the relationship disruption risk through operational continuity provisions. Whether it produces better outcomes depends on implementation. The first multi-vendor cycle is underway as of 2025–2026, and its results are the subject of Post VIII.

37
Years · No Challenge
Duration between NOTA's passage and the first legislation requiring competitive multi-vendor contracting for OPTN operations
5
Contract Components
Number of functional categories the 2023 act broke the single OPTN contract into — enabling competition without single-system transition risk
1984
The Origin
The year two reasonable legislative decisions created the structural conditions for a 37-year monopoly that 40 years of subsequent policy failed to challenge
FSA Note · Contract Architecture

The OPTN contract is a study in how incumbency accumulates into monopoly through the ordinary operation of switching costs, not through conspiracy or explicit protection. The decisions that created the conditions for UNOS's hold on the contract were made in 1984 for defensible reasons. The failure to challenge that hold across 37 renewal cycles was driven by genuine risk calculations at each cycle — disrupting a life-critical system is a real cost, not a pretext. But the aggregate outcome of individually rational decisions was a system that could not be held accountable for its performance, because the cost of replacing it was always calculated as higher than the cost of tolerating it. That calculation is the lock-in mechanism at its most complete. It does not require bad faith. It only requires that the disruption risk be real enough, and the incumbency protection be durable enough, that the status quo survives every reform moment until a legislative mechanism is finally applied that the administrative mechanism never produced.


Next · Post VII · The Spain Divergence — 52+ donors per million population. The Spanish Model as structural contrast. What the architecture looks like when the incentives are aligned differently.

Friday, May 29, 2026

THE ORGAN — V · The Board

The Organ · Post V · The Board
Trium Publishing House
Forensic System Architecture
thegipster.blogspot.com
Est. 2026 · Pennsylvania
The Organ
Post V of VIII
ORG-POST-V  ·  GOVERNANCE-RECORD  ·  INSULATION LAYER

The Board

Who Governed UNOS · Who Funded the Regulator · Who Set the Rules They Lived By

The UNOS board was populated primarily by transplant surgeons, transplant physicians, and OPO representatives — the same professionals whose centers and organizations operated under the policies the board set. The organization they governed was funded largely by the mandatory member fees those same centers paid. The regulator was funded by the regulated. The governor was the governed. Senate investigators documented the consequences.

OPTN / UNOS Board Composition · Governance Register · Historical ORG-POST-V · BOARD-REF-01 · PRE-2023
Transplant Professionals
~60–70%
Surgeons, physicians, transplant coordinators. Direct interest in allocation policies, center metrics, and OPO performance standards set by the board.
Patient / Public Representatives
~15–20%
Formally present. Outnumbered. Without institutional staff support or data resources equivalent to professional members.
Other (Hospital / Admin)
~15%
Hospital administrators, public health representatives. Some overlap with transplant center institutional interests.
Conflict-of-Interest Flag
Systemic
Members setting allocation policy and oversight standards for systems their own institutions operated within. Not disclosed as disqualifying conflict under UNOS governance framework.
01 The Self-Regulatory Structure

Regulatory capture, as examined in Post V of The Blood Economy, operates through proximity, expertise asymmetry, and the slow institutional drift that occurs when regulated parties participate substantially in setting the standards they are regulated by. The organ transplant system offers a case study in a more concentrated form: not merely capture through influence, but governance through direct participation. The transplant professionals who sat on the UNOS board were not lobbying the regulator. They were the regulator.

The OPTN board — technically the governing body of the Organ Procurement and Transplantation Network — and the UNOS board, which governed the nonprofit contractor operating the OPTN, were historically populated through a nomination and election process in which UNOS member organizations — transplant centers, OPOs, and transplant professionals — held the primary voice. The board that set allocation policy was chosen substantially by the people whose centers' outcomes would be governed by that policy. The board that set OPO performance standards was chosen substantially by OPO representatives. The board that oversaw the UNet algorithm was chosen substantially by the physicians whose patients the algorithm ranked.

The structural argument is precise: when the people who benefit from a policy are the people who set the policy, the policy will systematically reflect their interests. Not through corruption. Through the ordinary operation of institutional perspective — the genuine conviction, held by most board members, that their clinical expertise made them the right people to govern clinical allocation, combined with the structural incapacity to fully account for interests they did not share.

The board was not captured by the transplant professional community. It was constituted by it. The distinction matters. Capture implies an outside force bending an independent institution. This was an institution that was never independent — it was designed, from the beginning, as a community self-governance mechanism. The capture was structural.

OPTN / UNOS Board Composition · Approximate Historical Distribution ORG-POST-V · BC-01
Transplant Surgeons
Transplant Surgeons ~30%
OPO Reps ~18%
Tx Physicians ~16%
Patient/Public
Other
~64% professional
Conflict interest zone
Independent of allocation policy outcomes →
~36%
Transplant surgeons
OPO representatives
Transplant physicians
Patient/public reps
Other/admin
02 The Revenue Architecture

The governance conflict was compounded by the revenue architecture. UNOS's federal contract — the HRSA award that formally made it the OPTN contractor — was relatively small, running at approximately $6.5 to $7 million annually at various points in the system's history. But UNOS generated the majority of its revenue through a different channel: mandatory member fees paid by the transplant centers and OPOs that listed patients on the waitlist.

To list a patient on the OPTN waitlist, a transplant center must be a UNOS member. Membership carries mandatory fees. The scale of those fees varies by center volume, but the aggregate — UNOS reported total revenues of more than $80 million in recent years — means that the organization designated as the national regulator of organ allocation derived most of its operating budget from the organizations it was responsible for overseeing.

This is not a subtle conflict. It is a fundamental structural inversion: the regulator depends financially on the regulated. An organization that generates most of its revenue from membership fees paid by transplant centers has a structural incentive to maintain those centers' membership and goodwill. Policies that substantially disadvantage transplant centers — stricter discard rules, more aggressive outcome reporting, penalties for center selectivity — threaten the revenue base that sustains the regulating organization.

UNOS Revenue Architecture · The Funding Dependency · Pre-2023 ORG-POST-V · REV-01
HRSA / HHS
~$6.5–7M
Federal contract payment for operating the OPTN. Relatively small share of total UNOS revenue. Subject to HRSA oversight and contract terms.
~8% of total revenue · Primary accountability lever
UNOS
Operating budget
Transplant Centers · OPOs
~$75M+
Mandatory member fees paid by transplant centers to list patients on the waitlist, plus optional tools and services. The organizations UNOS governed paid for UNOS's governance. No opt-out available — membership required to list patients.
~92% of total revenue · Zero accountability lever
UNOS · Primary funder
Structural dependency
03 The Governance Map

The governance structure of the UNOS-OPTN relationship involved layers of boards, committees, and administrative bodies that, in theory, provided checks and balances across the system. In practice, the layers shared personnel, shared institutional interests, and were all ultimately administered by an organization whose board was constituted as described above.

UNOS / OPTN Governance Structure · Conflict Mapping ORG-POST-V · GOV-01
Operator + Standard-Setter
UNOS
Operated OPTN contract · Set allocation policy via OPTN board · Administered member fees from transplant centers · Governed its own oversight mechanisms · Funded by those it governed
Controls
Governed Entities
Transplant Centers · OPOs
Subject to UNOS allocation policy · Required to pay UNOS member fees · Represented on UNOS board · Their metrics determined by UNOS algorithm · Primary revenue source for UNOS
Nominal Overseer
HRSA / HHS
Awarded OPTN contract to UNOS · Received UNOS performance reports · Could theoretically rebid contract · Did not rebid for 37 years · Dependent on UNOS data for oversight
Oversight
Separate Nominal Overseer
CMS
Certified OPOs · Reimbursed organ recovery via Medicare · Never fully decertified an OPO pre-2022 · Operated separate from HRSA/OPTN oversight chain
STRUCTURAL FINDING: UNOS simultaneously operated the system, set the standards, governed the appeals process, and was funded by the entities it oversaw. HRSA and CMS operated in separate oversight silos with no unified accountability mandate. No single actor was responsible for the system's aggregate performance. The governance map was designed for coordination, not accountability.
04 What the Senate Found

The Senate Finance Committee investigation — led by Senators Wyden and Grassley across 2019 to 2022 — produced the most detailed public accounting of UNOS governance failures in the system's history. The investigation reviewed internal documents, interviewed current and former staff, examined complaint records, and analyzed financial disclosures. Its findings were specific, documented, and damaging.

Senate Finance Committee Findings · UNOS / OPTN Governance · 2019–2022 ORG-POST-V · SF-01
01
Critical
Safety Complaint Handling
UNOS's system for receiving, investigating, and resolving safety complaints from transplant professionals and patients was documented as inadequate. Complaints were understaffed, underprioritized, and in some cases not investigated at all. The organization responsible for overseeing safety was failing at its most basic safety function.
02
Critical
IT Systems Opacity and Security
The UNet matching system — the proprietary algorithm at the core of national organ allocation — was described as outdated, insufficiently secure, and resistant to independent government access. HRSA did not have full access to the system it was paying UNOS to operate. The federal contractor controlled the federal data.
03
Significant
Conflict of Interest Management
Board members with direct financial interests in allocation policy outcomes participated in policy decisions without adequate conflict disclosure or recusal requirements. The governance framework did not treat the board's structural composition as a conflict requiring management — only individual disclosed interests were subject to recusal requirements.
04
Significant
Executive Compensation and Spending
CEO compensation exceeding $650,000, combined with documented spending on entertainment, perks, and lobbying — at an organization claiming nonprofit mission status and operating under federal mandate — drew committee scrutiny. Lobbying expenditures spiked when reform proposals threatened the organization's operational model.
05
Significant
Operational Safety Failures
Investigators documented dozens of serious operational failures — organs shipped to wrong locations, communication breakdowns, testing errors that resulted in disease transmission to recipients. One analysis linked approximately 70 deaths to OPTN and OPO operational failures over a decade. These failures occurred within a system that had no meaningful external accountability mechanism.
06
Critical
Absence of Reform Response
Despite multiple GAO reports, OIG findings, and earlier congressional inquiries, UNOS had not implemented substantive governance reforms. The organization's response to documented failures was process improvement within its existing structure — not structural change. The Senate investigation triggered the legislative response (2023 OPTN Act) that the internal process had not produced.
05 The Patient Voice Problem

Patient representation on the UNOS board was not absent. It was structurally disadvantaged. Patient representatives attended the same board meetings, voted on the same policies, and formally had equal standing. But they came to those meetings without the institutional staff support, technical expertise, and data resources that transplant professional members brought. A transplant surgeon voting on allocation policy has spent a career in the system being governed. They understand it at a granular level. They have access to outcomes data from their own center's experience. They have colleagues throughout the national transplant community.

A patient representative — often a former transplant recipient or family member of a recipient, serving in a voluntary capacity — comes to the same meeting with personal experience, genuine commitment, and a perspective the professional members do not have. But they do not have equivalent institutional resources. The disparity in information and expertise between the two categories of board member is structural, and it systematically disadvantages the patients the system exists to serve.

92%
Revenue from Regulated
Estimated proportion of UNOS revenue from member fees paid by transplant centers and OPOs — the organizations UNOS was charged with overseeing
37
Years Unchallenged
Duration of UNOS's governance of the organ transplant system before the 2023 legislative reform separated OPTN board governance from contractor operations
2023
Governance Split
Year the Securing the US OPTN Act formally separated OPTN board governance from contractor operations — the key structural reform the Senate investigation produced
06 The 2023 Governance Reform

The Securing the US OPTN Act of 2023 addressed the governance conflict directly. The legislation required separation of the OPTN board's governance function from the OPTN contractor's operational function — the two had been conflated in UNOS for 37 years. Under the new framework, the OPTN board would set policy; the contractor would implement it; and the two would no longer be the same organization. The contractor could be competitive; the board's composition could be reformed; the structural merger of regulator and regulated could be undone.

This was the right reform. Whether it works depends on implementation — on whether the new board composition achieves meaningful independence from professional interests, whether the contractor split produces genuine accountability, and whether HRSA exercises the oversight authority it has always technically held but rarely used. Post VIII will examine what the modernization has produced and what it has not.

FSA Note · Insulation Layer · Governance

The UNOS board is the most complete example in this series of insulation operating as governance rather than rhetoric. The plasma industry used a word — "donation" — to insulate its extraction from critique. The organ system used a board — composed of the people being governed, funded by those people's fees — to insulate its allocation architecture from reform. The insulation was not maintained by language or lobbying alone. It was maintained by the governance structure itself. Every board meeting that produced a policy decision was simultaneously a demonstration that the system was being governed — by the right people, with the right expertise, in the right process. The form of governance provided the insulation. The substance of governance was what the Senate investigation documented.


Next · Post VI · The Contract — NOTA 1984. How a reasonable legislative decision became a 37-year monopoly. The rebid that never happened, and why.